Clinical Trials Directory

Trials / Completed

CompletedNCT03870074

CPET Predicts Long-term Survival and Positive Response to CRT

Cardiopulmonary Exercise Test Predicts Long-term Survival and Positive Response to Cardiac Resynchronization Therapy.

Status
Completed
Phase
Study type
Observational
Enrollment
122 (actual)
Sponsor
National Institute of Cardiology, Warsaw, Poland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study tested the usefulness of cardiopulmonary exercise test (CPET) in selection of potential responders to CRT.

Detailed description

Cardiac resynchronization therapy (CRT) is an acknowledged therapy of selected patients with heart failure (HF). One of the unresolved problems is high percentage of non-responders to CRT, reaching 40%. No single parameter, helpful in identifying non-responders prior to CRT implantation, was found. The study included patients with HF of ischemic or non-ischemic etiology, in NYHA class II-IV, EF≤35% and QRS≥120ms. All the patients had CRT implanted. Clinical evaluation, CPET and NT-proBNP levels measurement were performed before CRT implantation and after 3-6 months. Improvement in HF symptoms of one or more NYHA class correlated with two-years survival. It was used as the criterion of positive response to CRT.

Conditions

Timeline

Start date
2009-10-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2019-03-11
Last updated
2019-03-11

Source: ClinicalTrials.gov record NCT03870074. Inclusion in this directory is not an endorsement.